Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A straightforward framework to help newcomers pick their initial cryptocurrency with confidence.
25,030 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Investors await Federal Reserve Chair Jerome Powell's remarks as U.S. markets drift higher on rising oil prices. Anal...
Ecopetrol sits at the intersection of commodity pricing, currency risk, and refining margins. This guide breaks down ...
LyondellBasell shares have surged about 74% year-to-date, trading near $75 as of mid-March 2026. The rally comes desp...
Salesforce delivered a solid Q4 beat and announced a $50 billion buyback, but FY27 guidance disappointed investors. T...
The UK gilt market is spiraling, with the 10-year yield climbing to a 17-year high, signaling renewed stress for pens...
Global market shifts in 2026 make international exposure a potential anchor for retirement income and diversification...
Robotaxi chatter tends to focus on all-or-nothing automation. This article explains why Uber's hybrid network could b...
Reddit plans a major expansion of its new-grad hiring, arguing AI-native graduates can accelerate product development...
Tesla faces a fresh wave of headwinds as policy, competition, and software bets collide with a fragile growth narrati...
Icahn Enterprises just added a sizable stake in Centuri Holdings, signaling a continued conviction in North America's...
Citi trims its price target for Super Micro Computer to $25 from $39, citing governance and export-control concerns e...